hydroxycotinine

cytochrome P450 family 2 subfamily A member 6 ; Homo sapiens







30 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35197312 CYP2C19 plays a major role in the hepatic N-oxidation of cotinine. 2022 Feb 23 1
2 34520119 Nicotine metabolism and its association with CYP2A6 genotype among Indigenous people in Alaska who smoke. 2021 Nov 1
3 30815984 Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity. 2020 Jan 1
4 30381441 Nicotine-N'-Oxidation by Flavin Monooxygenase Enzymes. 2019 Feb 1
5 29158210 Longitudinal Influence of Pregnancy on Nicotine Metabolic Pathways. 2018 Feb 1
6 28181923 Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer. 2017 May 1
7 29048184 Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy. 2017 Oct 1
8 26818358 Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity. 2016 Mar 1
9 27488534 Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk. 2016 Oct 1 1
10 26014804 Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation. 2015 Aug 2
11 26132489 Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. 2015 1
12 23674838 Stability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes. 2013 Nov 2
13 23936477 Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake. 2013 3
14 22552800 Reproducibility of the nicotine metabolite ratio in cigarette smokers. 2012 Jul 1
15 22569203 CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people. 2012 Jun 1
16 22938167 Nicotine intake and smoking topography in smokers with bipolar disorder. 2012 Sep 2
17 20717551 Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population. 2010 Jul 4
18 20719908 Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness. 2010 Oct 1
19 19959692 Utility and relationships of biomarkers of smoking in African-American light smokers. 2009 Dec 2
20 18216723 A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent. 2008 Jan 4
21 18559554 Stability of the nicotine metabolite ratio in ad libitum and reducing smokers. 2008 Jun 2
22 19029401 Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer. 2008 Dec 1
23 16402128 Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. 2006 Apr 1
24 16765148 Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. 2006 Jun 2
25 17035386 CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. 2006 Oct 6
26 16141602 Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. 2005 Aug 1
27 16372023 Ethnic differences in nicotine metabolic rate among New Zealanders. 2005 Dec 16 1
28 12504349 Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. 2003 Feb 1 1
29 14577978 Nicotine metabolite ratio as a predictor of cigarette consumption. 2003 Oct 3
30 12024803 Effects of whole deletion of CYP2A6 on nicotine metabolism in humans. 2002 May 2